Corundum Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-11,000
Closed -$120K 66
2020
Q1
$120K Buy
+11,000
New +$203K 0.17% 56
2019
Q3
Sell
-11,250
Closed -$222K 67
2019
Q2
$222K Hold
11,250
0.26% 57
2019
Q1
$219K Hold
11,250
0.25% 59
2018
Q4
$185K Buy
+11,250
New +$226K 0.17% 72

Other funds holding SBRA

Corundum Group's SBRA Position: Q2 2020 in Review

Corundum Group sold out of Sabra Healthcare REIT (SBRA) in Q2 2020, closing a stake of 11,000 shares — an estimated $120K sold.

Corundum Group first reported a position in SBRA in Q4 2018 and held it in 4 quarters. The position peaked at $222K in Q2 2019. 317 funds tracked by Wall St. Rank hold SBRA as of Q2 2020.

  • Corundum Group reported no remaining Sabra Healthcare REIT position as of Q2 2020 after selling out during the quarter.
  • Corundum Group sold 11,000 Sabra Healthcare REIT shares in Q2 2020, an estimated $120K.
  • Corundum Group first reported a position in Sabra Healthcare REIT in Q4 2018 and held it in 4 quarters.
  • Corundum Group's Sabra Healthcare REIT position peaked at $222K in Q2 2019.
  • 317 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2020.

Based on Corundum Group's 13F filing for Q2 2020, filed 6 Aug 2020.